Cost-Effectiveness of Mental, Neurological, and Substance Use Disorders
2016
This report chapter reviews the available cost-effectiveness evidence for the different levels and underpinning strategies of the mental health care system, with a focus on information generated in or for lower and middle income countries. First, the chapter reviews the economic evidence for mental health prevention and protection at the population and community levels of the health and welfare system, including legislative, regulatory, and informational measures at the public policy level (population platform), as well as school, workplace, and community-based programs (community platform). Second, the chapter examines the economic evidence relating to the identification and treatment of mental, neurological, and substance use disorders (health care platform), focusing on the relative cost-effectiveness or efficiency of treatment programs implemented in nonspecialized versus more specialized health care settings. Finally, the chapter assesses the financial costs and budgetary implications of implementing or scaling up a set of prioritized, cost-effective interventions.
Annexes to this chapter:
- Annex 12C. List of Studies for Costs and Cost-Effectiveness
- Annex 12D. Cost-Effectiveness Results by Intervention
- Annex 12E. Cost Estimates by Intervention
Cost-Effectiveness of Mental, Neurological, and Substance Use Disorders
Source:
Levin C, Chisholm D. Chapter 12. Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders. Disease Control Priorities, Third Edition. The World Bank 2016; 4. http://www.dcp-3.org/mentalhealth